S. Haas Et Al. , "Predictors of NOAC versus VKA use for stroke prevention in patients with newly diagnosed atrial fibrillation: Results from GARFIELD-AF," AMERICAN HEART JOURNAL , vol.213, pp.35-46, 2019
Haas, S. Et Al. 2019. Predictors of NOAC versus VKA use for stroke prevention in patients with newly diagnosed atrial fibrillation: Results from GARFIELD-AF. AMERICAN HEART JOURNAL , vol.213 , 35-46.
Haas, S., Camm, A. J., Bassand, J., Angchaisuksiri, P., Cools, F., Corbalan, R., ... Gibbs, H.(2019). Predictors of NOAC versus VKA use for stroke prevention in patients with newly diagnosed atrial fibrillation: Results from GARFIELD-AF. AMERICAN HEART JOURNAL , vol.213, 35-46.
Haas, Sylvia Et Al. "Predictors of NOAC versus VKA use for stroke prevention in patients with newly diagnosed atrial fibrillation: Results from GARFIELD-AF," AMERICAN HEART JOURNAL , vol.213, 35-46, 2019
Haas, Sylvia Et Al. "Predictors of NOAC versus VKA use for stroke prevention in patients with newly diagnosed atrial fibrillation: Results from GARFIELD-AF." AMERICAN HEART JOURNAL , vol.213, pp.35-46, 2019
Haas, S. Et Al. (2019) . "Predictors of NOAC versus VKA use for stroke prevention in patients with newly diagnosed atrial fibrillation: Results from GARFIELD-AF." AMERICAN HEART JOURNAL , vol.213, pp.35-46.
@article{article, author={Sylvia Haas Et Al. }, title={Predictors of NOAC versus VKA use for stroke prevention in patients with newly diagnosed atrial fibrillation: Results from GARFIELD-AF}, journal={AMERICAN HEART JOURNAL}, year=2019, pages={35-46} }